Irinotecan | Health Canada Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
CDMO Prospector
- Demo Dashboard
Drugs in Dev.
News
Blog
Market Place
Login

Irinotecan
Health Canada Patents

Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

Contact Supplier

Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

Contact Supplier

HealthTech BioActives, leading globally in Flavonoids and Vitamin B12 Derivatives.

Contact Supplier

Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

Contact Supplier

Aspen API. More than just an API™

Contact Supplier

FAMAR CDMO- From early development to commercial manufacturing.

Contact Supplier

Irinotecan

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

68 API Suppliers, 29 USDMF, 13 CEP/COS, 10 JDMF, 7 EU WC, 12 KDMF, 12 NDC API, 37 Listed Suppliers, $ API Reference Price

68 API Suppliers
29 USDMF
13 CEP/COS
10 JDMF
7 EU WC
12 KDMF
12 NDC API
37 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

500 Drugs in Development

500 Drugs in Development

INTERMEDIATES

18 Intermediate Suppliers

18 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

177 FDF Dossiers, 65 FDA Orange Book, 64 Europe, 8 Canada, 10 Australia, 8 South Africa, 22 Listed Dossiers

177 FDF Dossiers
65 FDA Orange Book
64 Europe
8 Canada
10 Australia
8 South Africa
22 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

INJECTABLE;INJECTION - 100MG/5ML (20MG/ML), INJECTABLE;INJECTION - 300MG/15ML (20MG/ML), INJECTABLE;INJECTION - 40MG/2ML (20MG/ML), INJECTABLE, LIPOSOMAL;INTRAVENOUS - EQ 43MG BASE/10ML (EQ 4.3MG BASE/ML)

INJECTABLE;INJECTION - 100MG/5ML (20MG/ML)
INJECTABLE;INJECTION - 300MG/15ML (20MG/ML)
INJECTABLE;INJECTION - 40MG/2ML (20MG/ML)
INJECTABLE, LIPOSOMAL;INTRAVENOUS - EQ 43MG BASE/10ML (EQ 4.3MG BASE/ML)

RELATED EXCIPIENT COMPANIES

1 Rochem International Inc, 2 SPI Pharma, 1 Gangwal Healthcare, 1 Nanjing Well Pharmaceutical, 1 Shanghai Minbiotech, 2 Kirsch Pharma, 3 Actylis, 1 BioSpectra, 4 Nippon Fine Chemical, 11 Roquette, 1 Shijiazhuang Huaxu Pharmaceutical, 1 Zhejiang Huakang Pharmaceutical

1 Rochem International Inc
2 SPI Pharma
1 Gangwal Healthcare
1 Nanjing Well Pharmaceutical
1 Shanghai Minbiotech
2 Kirsch Pharma
3 Actylis
1 BioSpectra
4 Nippon Fine Chemical
11 Roquette
1 Shijiazhuang Huaxu Pharmaceutical
1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

9 Film Formers & Plasticizers, 9 Parenteral, 4 Fillers, Diluents & Binders, 4 Taste Masking, 4 Coating Systems & Additives, 3 Surfactant & Foaming Agents, 3 Emulsifying Agents, 2 Chewable & Orodispersible Aids, 2 Solubilizers, 2 Topical, 2 Co-Processed Excipients, 1 Soft Gelatin, 1 Direct Compression, 1 Thickeners and Stabilizers, 1 Dry Powder Inhalation

9 Film Formers & Plasticizers
9 Parenteral
4 Fillers, Diluents & Binders
4 Taste Masking
4 Coating Systems & Additives
3 Surfactant & Foaming Agents
3 Emulsifying Agents
2 Chewable & Orodispersible Aids
2 Solubilizers
2 Topical
2 Co-Processed Excipients
1 Soft Gelatin
1 Direct Compression
1 Thickeners and Stabilizers
1 Dry Powder Inhalation

DIGITAL CONTENT

64 News #PharmaBuzz

64 News #PharmaBuzz

GLOBAL SALES INFORMATION

11 US Medicaid Prescriptions, 44 Regulatory FDF Prices, 8 Annual Reports

11 US Medicaid Prescriptions
44 Regulatory FDF Prices
8 Annual Reports

MARKET PLACE

10 APIs, 9 FDF Dossiers

10 APIs
9 FDF Dossiers

PATENTS & EXCLUSIVITIES

23 US Patents, 2 US Exclusivities, 2 Health Canada Patents

23 US Patents
2 US Exclusivities
2 Health Canada Patents

REF. STANDARDS & IMPURITIES

15 Others

15 Others

$ API Ref.Price (USD/KG) : 22,133 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Reset all filters

2 All

01 2Pfizer Canada Inc.

filter Patent Reset all filters

2 All

01 12202531

02 12294031

filter Product Reset all filters

2 All

01 2Irinotecan Hydrochloride

filter Dosage Reset all filters

2 All

01 2Liquid

filter Exp Date Reset all filters

2 All

01 12015-10-11

02 12018-07-27

Product Main Page

01

Pfizer Canada Inc.

Irinotecan Hydrochloride

Luxepack

Not Confirmed

Pfizer Canada Inc.

Luxepack

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2015-10-11

Date Granted : 2005-05-03

Irinotecan Hydrochloride

Brand Name : CAMPTOSAR

Patent Number : 2202531

Filing Date : 1995-10-11

Strength per Unit : 20 mg / ml

Dosage Form : Liquid

Human Or VET : Human

Route of Administration : Injectable

Patent Expiration Date : 2015-10-11

Date Granted : 2005-05-03

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

Pfizer Canada Inc.

Irinotecan Hydrochloride

Luxepack

Not Confirmed

Pfizer Canada Inc.

Luxepack

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2018-07-27

Date Granted : 2005-01-18

Irinotecan Hydrochloride

Brand Name : CAMPTOSAR

Patent Number : 2294031

Filing Date : 1998-07-27

Strength per Unit : 20 mg / ml

Dosage Form : Liquid

Human Or VET : Human

Route of Administration : Injectable

Patent Expiration Date : 2018-07-27

Date Granted : 2005-01-18

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Ask Us!